Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott, Merck lead drug stocks higher
Marketwatch
Monday, September 28, 2009 - 11:13am
tags:
drug stocks, Abbott Laboratories, Merck
ViroPharma shares rise, analyst boosts outlook
Yahoo/AP
Monday, September 28, 2009 - 11:02am
tags:
ViroPharma, Cinryze, upgrades
M&A Action in the Swine Flu Market
Yahoo/Indie Research
Monday, September 28, 2009 - 10:54am
tags:
M&A, swine flu, H1N1, vaccines, GSK, AstraZeneca, JNJ
Another Diabetes Drug is Linked to Pancreas Inflammation
WSJ Online
Monday, September 28, 2009 - 10:53am
tags:
diabetes, pancreatitis, Januvia, Merck
Why Merck's Gardasil Franchise Will Be Battered by Entry of GSK's Cervarix
BNET Pharma
Monday, September 28, 2009 - 10:51am
tags:
GSK, Merck, Gardasil, vaccines, Cervarix, HPV
Abbott's Solvay Deal: Don't Get Too Excited
Forbes
Monday, September 28, 2009 - 10:47am
tags:
M&A, Abbott Laboratories, Solvay
[video] Sincerely Simcere: China Watch
TheStreet.com
Monday, September 28, 2009 - 10:41am
tags:
Simcere, China
GTx Has a Date
Yahoo/The Street.com
Monday, September 28, 2009 - 10:38am
tags:
GTx, Amgen, Discovery Labs
Crucell signs flu collaboration deal with J&J
Marketwatch
Monday, September 28, 2009 - 10:35am
tags:
Crucell, vaccines, Flu, JNJ
Abbott to acquire Solvay drug unit for $6.6 bln
Marketwatch
Monday, September 28, 2009 - 10:33am
tags:
Abbott Laboratories, Solvay, M&A
Bayer/Onyx Cancer Drug: Possible Additional Indication Looks Promising
Seeking Alpha
Sunday, September 27, 2009 - 11:02am
tags:
Bayer, ONYX Pharmaceuticals, regorafenib
Bayer’s Yaz Consumer’s Death Probed By Swiss Agency
Bloomberg
Sunday, September 27, 2009 - 11:01am
tags:
Bayer
China Biotech Week in Review: 3 Life Science IPOs Coming Up
Seeking Alpha
Sunday, September 27, 2009 - 10:56am
tags:
China, biotech
Tianyin Pharma Hits 2009 Targets, Continues Rapid Growth
Seeking Alpha
Sunday, September 27, 2009 - 10:54am
tags:
Tianyin Pharmaceutical
Watson, Teva Positioning for Generic Biotechnology Drugs
Orange County Business Journal
Sunday, September 27, 2009 - 10:51am
tags:
Watson Pharmaceuticals, Teva Pharmaceuticals, biotech
Abbott Nears Deal to Acquire Solvay's Pharmaceutical Unit
Wall Street Journal
Sunday, September 27, 2009 - 10:46am
tags:
Abbott Laboratories, Solvay
Have to Like the Risk / Reward in Antigenics Stock
Seeking Alpha
Sunday, September 27, 2009 - 10:45am
tags:
Antigenics
Taking Advantage of the BioDelivery Dip
Seeking Alpha
Sunday, September 27, 2009 - 10:43am
tags:
BioDelivery Sciences
Glaxo to Share Vaccine Technology With Brazil as Part of Sales Pact
Wall Street Journal
Saturday, September 26, 2009 - 11:25am
tags:
GSK, Brazil
Merck Receives Positive CHMP Opinion for JANUVIA® (sitagliptin) and JANUMET® (sitagliptin/metformin) as Add-On to Insulin in the European Union
Yahoo/BusinessWire
Saturday, September 26, 2009 - 11:23am
tags:
Merck, Januvia, Janumet

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.